Answers are grounded in this paper and cite their sources.
Case reports reveal diagnostic challenges in light-chain cardiac amyloidosis using scintigraphy and biopsies, suggesting further examination of abnormalities.
We report the cases of 3 patients with biopsy-proven light-chain cardiac amyloidosis (AL-CA) presenting with varying clinical manifestations and abnormal findings on Tc-based bone-avid scintigraphy, illustrating the diagnostic challenges of distinguishing AL-CA from transthyretin-related CA. All patients demonstrated typical electrocardiographic and echocardiographic features of CA, including low voltage and apical-sparing strain pattern. Despite abnormal scintigraphy suggestive of transthyretin-related CA, concurrent abnormal light-chain assays raised diagnostic uncertainty. Endomyocardial biopsy with mass spectrometry confirmed AL-CA in all cases. These cases emphasize the heterogeneous presentation of CA and the essential role of light-chain assays, regardless of the presence of myocardial uptake pattern on scintigraphy.
No takes yet. Share an insight, caveat, or question.
Ezegwu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: